Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.

In a groundbreaking move, the Centers for Medicare and Medicaid Services (CMS) announced potential savings of up to $685 million for over 55 million Medicare Part D enrollees. This initiative, part of ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

Medicare prescription drug costs are entering a new phase in 2026, and for millions of beneficiaries the changes could ...

The savings go into effect in 2027 and are expected to save billions for government health program.

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The Centers for Medicare and Medicaid Services has announced the expected savings from a second round of Medicare drug price negotiations. There is a net savings of 44%, or $12 billion, from ...

(CNN) — Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced ...